Galmed Pharmaceuticals Delays PSC Study Initiation, Stock Dips
Galmed Pharmaceuticals Ltd, a renowned clinical-stage biopharmaceutical company specializing in liver, metabolic, and fibrotic diseases, has encountered an unexpected delay in the commencement of its